ARTICLE | Clinical News
Onconase RNase enzyme: ACEL began a new Phase III trial in patients with advanced pancreatic cancer.
August 26, 1996 7:00 AM UTC
An ongoing Phase III trial of Onconase plus tamoxifen, compared to 5-FU, will now enroll patients who have been treated with Gemzar. In both trials, Onconase is given weekly, while tamoxifen is given ...